| 摘要 |
<p>The present invention relates to a method for diagnosing, in vitro, a neurodegenerative disease in an individual, in which:-the level of the double-stranded RNA-dependent protein kinase (PKR) in a sample of cerebrospinal fluid from the individual is determined,-it is deduced therefrom whether the individual is suffering from a neurodegenerative disease.</p> |
